Picomole is a revolutionary brand at the forefront of disease detection technology. With a powerful platform that screens for often life-threatening diseases using only breath, Picomole is poised to redefine routine screening. Their technology works by identifying disease biomarkers through breath analysis, potentially revolutionizing multi-disease screening.

Their ultimate goal is to make their simple breath test available in physician offices, clinics, and pharmacies. Picomole's vision is to create a new paradigm for early-disease detection that improves the quality of life and saves lives. They are focused on developing an accurate breath test for early-stage breast cancer detection in women.

Their commitment to quality and innovation is demonstrated by their ISO 13485 certification, which ensures the highest standards for safety and quality. With groundbreaking research and partnerships, Picomole is making significant strides in the field of breath-based diagnostic technology. Contact them today to learn more about their life-saving solutions